Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Counsyl

2007 FOUNDED
M&A STATUS
601-700 EMPLOYEES
M&A LATEST DEAL TYPE
$375M LATEST DEAL AMOUNT
Description

Provider of a genomics and DNA screening technology platform intended to offer people access to information about their bodies. The company's platform uses custom-built robots to process blood and saliva samples working alongside a team of scientists and engineers to simultaneously analyze thousands of DNA samples with precision, accuracy and unparalleled efficiency, enabling individuals to understand their DNA and how it can impact important health decisions.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Other Healthcare Services
Acquirer
Primary Office
  • 180 Kimball Way
  • South San Francisco, CA 94080
  • United States

+1 (888) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Counsyl’s full profile, request a free trial.

Counsyl Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 31-Jul-2018 $375M 00000 00000 Completed Generating Revenue
6. Debt - General 06-Nov-2017 0000 00000 Completed Generating Revenue
5. Senior Debt 01-Aug-2015 0000 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 08-May-2014 000.00 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 24-Aug-2012 00.000 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 16-Mar-2010 $36.1M $43.6M 0000 Completed Startup
1. Early Stage VC (Series A) 13-Apr-2009 $7.5M $7.5M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Counsyl Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series D 0,000,000 00.000000 00 000.00 000.00 00 000.00 00.00
Series C 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 7,138,317 $0.001000 8% $5.05 $5.05 1x $5.05 34.22%
Series A 1,752,337 $0.001000 8% $4.28 $4.28 1x $4.28 8.4%
To view this company’s complete Cap Table, request access »

Counsyl Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Personalis Venture Capital-Backed Menlo Park, CA 000 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Mountain View, CA 000 00000 0000000000 0 00000
0000000 Venture Capital-Backed Cambridge, United Kingdom 00000 00000000000 00000
00000 Corporation New York, NY
000000000 Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Counsyl Former Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Aarin Capital Venture Capital Minority 000 0000 000000 0
Andrew Boszhardt Angel (individual) Minority 000 0000 000000 0
Aydin Senkut Angel (individual) Minority 000 0000 000000 0
Felicis Ventures Venture Capital Minority 000 0000 000000 0
Founders Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »

Counsyl Executive Team (18)

Name Title Board
Seat
Contact
Info
Peter Kang MD Laboratory Director
Joel Jung Chief Financial Officer
Peter Soparkar JD Chief Legal Officer & People Team Head

15 Former Executives

You’re viewing 3 of 18 executives. Get the full list »